Study guide

19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

NBCRNA CRNA Certified Registered Nurse Anesthetist NCE

Track your progress as you read

Finished sections get a check mark.

1 Chapter 1: Cardiovascular, Respiratory & CNS Physiology & Pathophysiology

1.1 Cardiovascular Physiology, Hemodynamics & Ischemic Heart Disease 1.2 Respiratory Physiology, Lung Volumes & Chronic Pulmonary Pathophysiology 1.3 Central & Autonomic Nervous System Physiology & Neurological Disorders

2 Chapter 2: Hepatorenal, Endocrine & Hematologic/Immune Systems

2.1 Renal Physiology, Glomerular Filtration & Acid-Base Balance 2.2 Hepatic Physiology, Drug Clearance & Gastrointestinal Considerations 2.3 Endocrine Disorders, Hematology, Coagulation & Immune Mechanisms

3 Chapter 3: Anesthetic Pharmacology: Inhalation Agents, Intravenous Anesthetics & Sedatives

3.1 Inhalation Anesthetics: Uptake, Distribution, Blood/Gas Solubility & MAC 3.2 Intravenous Hypnotics: Propofol, Etomidate, Ketamine & Barbiturates 3.3 Opioid Agonists/Antagonists, Benzodiazepines & Reversal Pharmacology

4 Chapter 4: Anesthetic Pharmacology: Neuromuscular Blockers, Local Anesthetics & Physics

4.1 Neuromuscular Blocking Agents & Reversal: Anticholinesterases vs Sugammadex 4.2 Local Anesthetics: Mechanism, Potency, Toxicity (LAST) & Vasoconstrictors 4.3 Applied Physics, Gas Laws, Fluid Dynamics & Anesthesia Mathematics

5 Chapter 5: Anesthesia Delivery Systems & Gas Supplies

5.1 Medical Gas Supply Systems, Cylinders, Regulators & Safety Index Systems (PISS/DISS) 5.2 Anesthesia Machine High, Intermediate & Low Pressure Systems & Failsafe Mechanisms 5.3 Vaporizer Technology: Variable-Bypass vs Desflurane Vaporizers & Machine Checkout

6 Chapter 6: Breathing Circuits, CO2 Absorption & Ventilators

6.1 Breathing Circuits: Circle System, Mapleson Classifications & Dead Space 6.2 Carbon Dioxide Absorption: Soda Lime Chemistry, Desiccation, Carbon Monoxide & Compound A 6.3 Anesthesia Ventilators, Pressure/Volume Modes, APL Valves & Waste Gas Scavenging

7 Chapter 7: Airway Equipment & Advanced Airway Instrumentation

7.1 Face Masks, Supraglottic Airways (LMA Types) & Endotracheal Tubes 7.2 Direct Laryngoscopy (Mac/Miller) & Video Laryngoscopy 7.3 Fiberoptic Intubation, Bronchial Blockers, Double-Lumen Tubes & Surgical Airways

8 Chapter 8: Patient Monitoring, Hemodynamics & Electrosurgical Safety

8.1 Noninvasive Monitoring: Pulse Oximetry, Capnography Waveforms & Temperature 8.2 Invasive Hemodynamics: Arterial Lines, CVP & Pulmonary Artery Catheters 8.3 Neuromuscular Monitoring (TOF/PTC), Depth of Anesthesia (EEG/BIS) & Electrical Safety

9 Chapter 9: Preoperative Assessment, Risk Stratification & Preparation

9.1 Preoperative History, Physical Examination & ASA Physical Status Classification 9.2 Cardiac & Pulmonary Risk Stratification, Diagnostic Testing & Optimization 9.3 Preoperative Fasting Guidelines, Aspiration Prophylaxis & Premedication

10 Chapter 10: Fluid Management, Blood Component Therapy & Coagulation Monitoring

10.1 Crystalloids vs Colloids, Maintenance & Deficit Calculations 10.2 Blood Component Therapy, Transfusion Triggers & Massive Transfusion Protocols 10.3 Point-of-Care Coagulation: TEG, ROTEM & Perioperative Coagulopathies

11 Chapter 11: Airway Management Strategies & Difficult Airway Algorithms

11.1 Difficult Airway Assessment: Mallampati, Cormack-Lehane & Airway Predictors 11.2 ASA Difficult Airway Algorithm: Anticipated vs Unanticipated Difficult Airway 11.3 "Cannot Intubate, Cannot Oxygenate" (CICO) & Emergency Front-of-Neck Access (eFONA)

12 Chapter 12: General Anesthesia: Induction, Maintenance, Emergence & TIVA

12.1 Rapid Sequence Induction (RSI), Cricoid Pressure & Intubation Protocols 12.2 Balanced Anesthesia vs Total Intravenous Anesthesia (TIVA) Principles 12.3 Emergence, Extubation Criteria, Deep vs Awake Extubation & Laryngospasm

13 Chapter 13: Regional Anesthesia: Neuraxial Blocks

13.1 Spinal Anesthesia: Anatomy, Physiology, High Spinal & Complications 13.2 Epidural & Combined Spinal-Epidural (CSE) Techniques & PDPH 13.3 Neuraxial Anticoagulation Guidelines (ASRA) & Epidural Hematoma

14 Chapter 14: Regional Anesthesia: Peripheral Nerve Blocks & Ultrasound Guidance

14.1 Upper Extremity Peripheral Nerve Blocks: Interscalene, Supraclavicular, Axillary 14.2 Lower Extremity & Truncal Blocks: Femoral, Sciatic, TAP & ESP Blocks 14.3 Ultrasound Physics, Needle Visualization & LAST Rescue Protocols

15 Chapter 15: Perioperative Safety, Positioning, PACU, Ethics & Professional Practice

15.1 Surgical Positioning Complications: Nerve Injuries & Physiologic Changes 15.2 PACU Discharge Criteria, PONV Management, Hypoxemia & Emergence Delirium 15.3 Malignant Hyperthermia Protocol & Operating Room Crisis Management 15.4 CRNA Ethics, Informed Consent, Scope of Practice & Wellness Initiatives

16 Chapter 16: Obstetric & Gynecologic Anesthesia

16.1 Maternal Physiology & Pharmacokinetics Across Trimesters 16.2 Labor Analgesia & Anesthesia for Cesarean Delivery 16.3 Obstetric Emergencies: Preeclampsia, Hemorrhage & Amniotic Fluid Embolism 16.4 Nonobstetric Surgery in the Pregnant Patient

17 Chapter 17: Pediatric Anesthesia

17.1 Pediatric Anatomy, Physiology, Airway & Developmental Pharmacology 17.2 Pediatric Induction, Maintenance, Fluids & Emergence Agitation 17.3 Pediatric Respiratory Emergencies: Croup, Epiglottitis & Laryngospasm

18 Chapter 18: Geriatric, Bariatric & Ambulatory Anesthesia

18.1 Geriatric Physiology, Pharmacodynamics & Postoperative Delirium/POCD 18.2 Bariatric Anesthesia: Obesity Hypoventilation, OSA & Dosing Adjustments 18.3 Ambulatory Surgery Selection Criteria & ERAS Protocols

19 Chapter 19: Cardiac, Vascular & Thoracic Anesthesia

19.1 Valvular Heart Disease, CAD & Cardiopulmonary Bypass Management 19.2 Vascular Anesthesia: Carotid Endarterectomy & Aortic Cross-Clamping 19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

20 Chapter 20: Neurosurgical, Intra-Abdominal, Extrathoracic, Head/Neck & Trauma Anesthesia

20.1 Neurosurgical Anesthesia: ICP Dynamics, Craniotomy & Venous Air Embolism 20.2 Intra-Abdominal, Laparoscopy & Endocrine Tumor Anesthesia (Pheochromocytoma, Carcinoid) 20.3 ENT/Shared Airway, Extrathoracic Procedures & Trauma/Burn Resuscitation

21 Chapter 21: Neurologic, Gastrointestinal & Substance-Related Pathophysiology and Pharmacology

21.1 Neurodegenerative & Demyelinating Disease and Antiparkinsonian Pharmacology 21.2 Gastrointestinal & Exocrine Pancreatic Disorders: Esophageal, Gastric, Pancreatitis & Malabsorption 21.3 Cannabinoids, Herbal Remedies & Dietary Supplements

22 Chapter 22: Imaging Safety, Patient Warming & Infusion Technology

22.1 Fluoroscopy, Radiography & Radiation Safety in Anesthetizing Locations 22.2 Patient Warming Equipment & Rapid Infusion Devices

23 Chapter 23: Pain Medicine: Theory, Chronic Pain & Interventional Procedures

23.1 Pain Theory: Nociception, Sensitization & Chronic Pain Pathophysiology 23.2 Chronic Pain Management, Medication-Assisted Therapy & the Opioid-Tolerant Patient 23.3 Interventional Pain Procedures & Anesthesia for Pain Management Cases

24 Chapter 24: Professional Practice: Research Ethics, Error Disclosure & Provider Infection Control

24.1 Research Ethics, IRB Oversight & Protection of Human Subjects 24.2 Disclosure of Errors and Injuries, Adverse Event Reporting & Just Culture 24.3 Provider Infection Control: PPE, Air Handling & Occupational Exposure

25 Chapter 25: Neurosurgical Subspecialty Procedures

25.1 Cerebral Aneurysm Clipping, AVM Resection & Subarachnoid Hemorrhage 25.2 Transsphenoidal Hypophysectomy & Pituitary Surgery 25.3 Stereotactic Procedures, Deep Brain Stimulation & Awake Craniotomy 25.4 CSF Diversion, Burr Holes, Ventriculoperitoneal Shunts & Decompressive Craniectomy

26 Chapter 26: Head, Neck, Nasal, Dental & Ophthalmic Anesthesia

26.1 Nasal & Sinus Surgery, Nasotracheal Intubation & Craniofacial Procedures 26.2 Dental, Orthodontic, Oral-Maxillofacial & Ophthalmic Anesthesia 26.3 Neck Tumors, Radical Neck Dissection, Lymph Node Biopsy & Thyroid/Parathyroid Surgery

27 Chapter 27: Orthopedic & Extremity Anesthesia

27.1 Total Joint Arthroplasty, Bone Cement Implantation Syndrome & Tourniquet Physiology 27.2 Closed Reduction, Hand and Foot Procedures & Intravenous Regional (Bier) Block

28 Chapter 28: Non-Operating-Room Anesthesia: Interventional, Imaging & Radiation Therapy

28.1 Interventional and Neurointerventional Radiology Anesthesia 28.2 Radiation Therapy, Diagnostic Imaging & MRI-Suite Anesthesia

29 Chapter 29: Special Populations: Substance Use Disorder, Immunocompromised & Oncology Patients

29.1 Acute Intoxication, Withdrawal Syndromes & Perioperative Complications 29.2 Anesthesia for the Immunocompromised & Oncology Patient

19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

Key Takeaways Explain This Topic AI

Indications for One-Lung Ventilation (OLV) are classified as absolute (isolation for massive hemoptysis/purulent infection, ventilation distribution in bronchopleural fistula/giant bullae, unilateral bronchopulmonary lavage) versus relative (surgical exposure for VATS, lobectomy, pneumonectomy, and esophageal resection).

Left-sided Double-Lumen Tubes (DLT) are preferred in >90% of thoracic procedures due to favorable left mainstem anatomy; Right-sided DLTs require alignment of a slotted aperture with the Right Upper Lobe (RUL) takeoff (1.5-2.5 cm from carina) and carry high obstruction risk; tube positioning must always be confirmed via fiberoptic bronchoscopy.

Hypoxic Pulmonary Vasoconstriction (HPV) is an essential reflex triggered by alveolar hypoxia (PAO₂ < 100 mmHg) that constricts non-ventilated arterioles, diverting 40-50% of blood flow to the ventilated lung (reducing shunt to 20-25%); HPV is inhibited by volatile anesthetics >1.0-1.5 MAC, vasodilators, hypocapnia, hypothermia, and excessive dependent PEEP.

The stepwise rescue protocol for refractory hypoxemia during OLV is: 1) Verify tube position with fiberoptic bronchoscopy and suction secretions, 2) Increase FiO₂ to 1.0, 3) Apply CPAP (2-5 cmH₂O) with 100% O₂ to the non-dependent lung (the single most effective intervention), 4) Apply PEEP (5-10 cmH₂O) to the dependent lung, 5) Resume intermittent two-lung ventilation.

Mediastinal Mass Syndrome: Anterior mediastinal masses can cause catastrophic total airway and cardiovascular collapse upon induction due to loss of lung volume and muscle tone; management mandates preserving spontaneous breathing, avoiding neuromuscular blockers, repositioning (prone/lateral/sitting), and standby femoral-femoral CPB/ECMO under local anesthesia.

Last updated: August 2026

19.3 Thoracic Anesthesia: One-Lung Ventilation & Hypoxic Pulmonary Vasoconstriction

Thoracic anesthesia presents complex challenges in respiratory physiology, gas exchange, and airway instrumentation. Anesthesia providers must manage non-physiologic lateral decubitus positioning, optimize Hypoxic Pulmonary Vasoconstriction (HPV) to minimize intrapulmonary shunting, master double-lumen endobronchial tube mechanics, and prevent catastrophic airway collapse in patients with mediastinal masses.

1. Indications for One-Lung Ventilation (OLV): Absolute vs. Relative +---------------------------------------------------------------------------------------------------------+

  • | INDICATIONS FOR ONE-LUNG VENTILATION (OLV) |
  • +----------------------------------------------------+----------------------------------------------------+
  • | ABSOLUTE INDICATIONS (Mandatory Isolation) | RELATIVE INDICATIONS (Surgical Exposure) |
  • +----------------------------------------------------+----------------------------------------------------+
  • | 1. **Isolation to Prevent Contamination:** | 1. **High-Priority Surgical Exposure:** |
  • | • Massive Pulmonary Hemorrhage (>500 mL/24h) | • Video-Assisted Thoracoscopic Surgery (VATS) |
  • | • Purulent Infection / Pulmonary Abscess | • Open Thoracotomy (Lobectomy / Pneumonectomy) |
  • | 2. **Control of Ventilation Distribution:** | • Thoracic Aortic Aneurysm Repair (TAAA) |
  • | • Bronchopleural Fistula (BPF) | • Esophageal Resection / Minimally Invasive Esoph|
  • | • Giant Unilateral Bulla / Lung Cyst | 2. **Medium-Priority Surgical Exposure:** |
  • | • Major Tracheobronchial Tree Disruption / Rupt | • Anterior Thoracic Spine Surgery |
  • | 3. **Unilateral Bronchopulmonary Lavage:** | • Mediastinal Mass Resection |
  • | • Pulmonary Alveolar Proteinosis (PAP) | • Thoracic Sympathectomy |
  • +----------------------------------------------------+----------------------------------------------------+

2. Double-Lumen Endotracheal Tubes (DLT) & Bronchial Blockers +---------------------------------------------------------------------------------------------------------+

  • | LEFT-SIDED DLT VS. RIGHT-SIDED DLT |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Characteristic | Left-Sided Double-Lumen Tube (DLT) | Right-Sided Double-Lumen Tube (DLT) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Clinical Use** | • **Preferred for >90% of Cases** | • Used ONLY when Left DLT contraindicated|
  • | | • Used for BOTH Left & Right surgery | (left pneumonectomy, left main lesion) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Anatomical Margin** | • Left mainstem is **4.5 - 5.0 cm** | • Right mainstem is short (**1.5-2.5 cm**|
  • | **of Safety** | long before branching into lobar | to Right Upper Lobe [RUL] takeoff) |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Cuff & Aperture** | • Simple cylindrical bronchial cuff | • Must align a specialized **slotted cuff|
  • | **Design** | resting inside left mainstem | aperture** directly over the RUL lumen |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Primary Hazard** | • Cuff herniation over carina into | • **Obstruction of RUL orifice** → |
  • | | trachea (causes bilateral leak) | RUL atelectasis & severe hypoxemia |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • Sizing, Insertion & Depth Formulas for DLTs

Sizing Guidelines:

Females: 35 Fr 35 \text{ Fr} 35 Fr (height < 160 cm < 160 \text{ cm} < 160 cm ) or 37 Fr 37 \text{ Fr} 37 Fr (height > 160 cm > 160 \text{ cm} > 160 cm ).

Males: 39 Fr 39 \text{ Fr} 39 Fr (height < 175 cm < 175 \text{ cm} < 175 cm ) or 41 Fr 41 \text{ Fr} 41 Fr (height > 175 cm > 175 \text{ cm} > 175 cm ).

Depth Formula (at teeth/incisors): Depth (cm) = 12 + [ 0.1 × Height (cm) ] or 29 cm for 170 cm height ( ± 1 cm per 10 cm height ) \text{Depth (cm)} = 12 + [0.1 \times \text{Height (cm)}] \quad \text{or} \quad 29 \text{ cm for } 170 \text{ cm height } (\pm 1 \text{ cm per } 10 \text{ cm height}) Depth (cm) = 12 + [ 0.1 × Height (cm) ] or 29 cm for 170 cm height ( ± 1 cm per 10 cm height ) +-------------------------------------------------------------------------+

  • | FIBEROPTIC BRONCHOSCOPY (FOB) CONFIRMATION STEPS |
  • +-------------------------------------------------------------------------+
  • | Step 1: Pass Bronchoscope through TRACHEAL Lumen: |
  • | • View the Carina directly. |
  • | • Confirm tracheal lumen is in distal trachea above carina. |
  • | • Confirm top edge of blue bronchial cuff is resting JUST |
  • | BELOW the carina inside the left mainstem (no herniation). |
  • | |
  • | Step 2: Pass Bronchoscope through BRONCHIAL Lumen: |
  • | • Advance past bronchial tip into left mainstem. |
  • | • Confirm unobstructed view of Left Upper and Lower Lobe ostia. |
  • +-------------------------------------------------------------------------+
  • Bronchial Blockers (e.g., Arndt, Cohen, EZ-Blocker, Univent)

Indications: Known difficult airway (placed through standard single-lumen ETT), presence of a tracheostomy, pediatric patients (where smallest DLT is too large), patients already intubated in ICU, or when postoperative mechanical ventilation is planned.

Disadvantages: Slower lung deflation; easily dislodged into main trachea during surgical manipulation.

3. Physiology of Hypoxic Pulmonary Vasoconstriction (HPV) [THE HYPOXIC PULMONARY VASOCONSTRICTION (HPV) REFLEX]

  • Non-Ventilated (Operative) Lung Ventilated (Dependent) Lung
  • +-----------------------------+ +-----------------------------+
  • | Alveolar Hypoxia | | Continuous Ventilation |
  • | (PAO₂ < 50-100 mmHg) | | (PAO₂ ≈ 150-500 mmHg) |
  • +--------------+--------------+ +--------------+--------------+
  • | ^
  • v |
  • [Mitochondrial Redox Signaling] |
  • | |
  • v |
  • [Inhibition of Kv K⁺ Channels] |
  • | |
  • v |
  • [Membrane Depolarization] |
  • | |
  • v |
  • [L-Type Ca²⁺ Influx into Smooth Muscle] |
  • | |
  • v |
  • **PRE-CAPILLARY ARTERIOLAR CONSTRICTION** |
  • | |
  • +====== Blood Flow Diverted (40-50%) =======+
  • (Reduces Shunt: 50% → 20-25%)

Mechanism: HPV is an intrinsic protective autoregulatory reflex unique to the pulmonary circulation. Precapillary pulmonary arteriolar smooth muscle cells detect low alveolar oxygen tension ( P A O 2 < 100 mmHg P_A O_2 < 100 \text{ mmHg} P A ​ O 2 ​ < 100 mmHg , maximal at P A O 2 < 50 mmHg P_A O_2 < 50 \text{ mmHg} P A ​ O 2 ​ < 50 mmHg , with mixed venous P v ˉ O 2 P_{\bar{v}}O_2 P v ˉ ​ O 2 ​ playing a minor secondary role).

Shunt Reduction: In the lateral position with both lungs ventilated, the dependent lung receives ≈ 60 % \approx 60\% ≈ 60% of blood flow and the non-dependent lung receives ≈ 40 % \approx 40\% ≈ 40% . Upon initiating OLV without HPV, the non-dependent lung creates an obligatory ≈ 40 − 50 % \approx 40 - 50\% ≈ 40 − 50% right-to-left transpulmonary shunt. HPV constricts non-dependent arterioles, diverting 40 − 50 % 40 - 50\% 40 − 50% of its blood flow to the dependent ventilated lung , reducing the total shunt down to 20 − 25 % 20 - 25\% 20 − 25% .

4. Factors & Pharmacologic Agents Inhibiting HPV +---------------------------------------------------------------------------------------------------------+

  • | PHARMACOLOGIC & PHYSIOLOGIC MODULATORS OF HPV |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | Modulator / Factor | Mechanism of Action | Clinical Impact on OLV Oxygenation |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Volatile Agents** | • Dose-dependent smooth muscle relax | • **< 1.0 MAC:** Minimal inhibition |
  • | (Sevo/Des/Iso) | • Blunts voltage-gated Ca²⁺ influx | • **> 1.0 - 1.5 MAC:** Significant HPV |
  • | | | inhibition → increased shunt & hypoxia |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Intravenous TIVA** | • Propofol, Ketamine, Etomidate, | • **DO NOT INHIBIT HPV!** |
  • | (Propofol/Opioids) | Opioids, Dexmedetomidine | • Ideal maintenance during severe shunt |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Direct Vasodilators**| • Direct pulmonary smooth muscle rel | • **INHIBIT HPV SEVERELY:** Nitroprusside|
  • | | • Increase cGMP / cAMP / block Ca²⁺ | Nitroglycerin, CCBs, Milrinone, Silden |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Ventilatory / Acid-**| • **Hypocapnia / Alkalosis:** Inhibit| • Hyperventilation worsens shunt; |
  • | **Base Mechanics** | • **Acidosis / Hypercapnia:** Enhance| • Mild permissive hypercapnia acceptable |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Temperature** | • **Hypothermia:** Inhibits HPV | • Maintain normothermia to preserve HPV |
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Hemodynamics** | • Excessively high LAP / PAP | • High pressures overcome arteriolar |
  • | | forces blood through hypoxic bed | constriction; hypervolemia worsens shnt|
  • +-----------------------+--------------------------------------+------------------------------------------+
  • | **Excessive PEEP in** | • High alveolar pressure compresses | • Diverts blood BACK into non-ventilated |
  • | **Dependent Lung** | dependent alveolar capillaries | hypoxic lung, worsening hypoxemia! |
  • +-----------------------+--------------------------------------+------------------------------------------+

5. Stepwise Management of Refractory Hypoxemia during OLV +-------------------------------------------------------------------------+

  • | STEPWISE RESCUE ALGORITHM FOR OLV HYPOXEMIA |
  • +-------------------------------------------------------------------------+
  • | |
  • | **STEP 1: Verify DLT Position with Fiberoptic Bronchoscope (FOB)** |
  • | • Tube malposition is the #1 cause of sudden intraoperative hypoxemia |
  • | • Clear blood/mucus secretions with suction through both lumens |
  • | |
  • | **STEP 2: Increase FiO₂ to 1.0 (100% O₂)** |
  • | • Maximize alveolar oxygen gradient in dependent lung |
  • | |
  • | **STEP 3: Apply CPAP (2 - 5 cmH₂O) with 100% O₂ to Non-Dependent Lung**|
  • | • **THE SINGLE MOST EFFECTIVE MANEUVER TO REDUCE SHUNT!** |
  • | • Delivers O₂ to non-ventilated alveoli without disrupting surgery |
  • | |
  • | **STEP 4: Apply PEEP (5 - 10 cmH₂O) to Dependent (Ventilated) Lung** |
  • | • Recruits atelectatic dependent alveoli and increases FRC |
  • | • CAUTION: Excessive PEEP (>10) increases PVR and worsens shunt |
  • | |
  • | **STEP 5: Communicate with Surgeon & Resume Intermittent Two-Lung Vent**|
  • | • If SpO₂ < 85%, reinflate operative lung immediately |
  • | • In pneumonectomy: early clamping of operative pulmonary artery |
  • | instantly eliminates right-to-left shunt |
  • +-------------------------------------------------------------------------+
  • 6. Mediastinal Mass Syndrome & Anesthetic Crisis Management

Patients presenting with large anterior or middle mediastinal masses (e.g., "4 Ts": Thymoma, Teratoma, Thyroid goiter, "Terrible" Lymphoma ) face life-threatening airway and cardiovascular collapse upon induction of general anesthesia. +---------------------------------------------------------------------------------------------------------+

  • | PATHOPHYSIOLOGY OF MEDIASTINAL MASS CRISIS |
  • +---------------------------------------------------------------------------------------------------------+
  • | 1. **Loss of Lung Volumes (FRC ↓):** Induction of anesthesia causes cephalad diaphragm shift, |
  • | shortening the thoracic cavity and increasing extrinsic mass compression on the trachea. |
  • | 2. **Loss of Chest Wall Tone:** Paralysis eliminates chest wall expansion forces that keep airway patent|
  • | 3. **Loss of Bronchial Smooth Muscle Tone:** Neuromuscular blockade flaccidly collapses airway |
  • | 4. **Vascular Compression:** Mass compresses Superior Vena Cava (SVC Syndrome), Pulmonary Artery, |
  • | and Right Atrium, causing instantaneous loss of preload, acute cor pulmonale, and cardiac arrest. |
  • +---------------------------------------------------------------------------------------------------------+
  • Preoperative Risk Stratification

Symptoms: Severe orthopnea (inability to lie flat without choking), stridor, upper extremity/facial cyanosis and edema (SVC syndrome), syncope when supine.

Diagnostic CT & Spirometry: Tracheal cross-sectional area reduced by > 50 % >50\% > 50% (or tracheal diameter < 10 mm <10 \text{ mm} < 10 mm ) indicates extreme risk; upright vs. supine flow-volume loops showing positional dynamic or fixed intrathoracic obstruction. +-------------------------------------------------------------------------+

  • | MEDIASTINAL MASS SYNDROME: ANESTHETIC CRISIS PROTOCOL |
  • +-------------------------------------------------------------------------+
  • | 1. **Maintain Spontaneous Ventilation:** |
  • | • Awake fiberoptic intubation or inhalational/ketamine induction |
  • | • **STRICTLY AVOID NEUROMUSCULAR BLOCKERS!** |
  • | 2. **Pass Endotracheal Tube Distal to Obstruction:** |
  • | • Use reinforced/armored tube; position tip past extrinsic mass |
  • | 3. **Immediate Positional Change:** |
  • | • If airway or vascular collapse occurs, immediately roll patient |
  • | into **LATERAL, PRONE, or SITTING (SEMI-FOWLER)** position |
  • | 4. **Standby Rigid Bronchoscopy:** Immediate rigid stenting capability |
  • | 5. **Standby Femoral-Femoral CPB / ECMO:** In severe tracheal or pul- |
  • | monary artery compression, cannulate groin vessels under LOCAL |
  • | anesthesia with CPB primed and ready BEFORE general anesthesia |
  • +-------------------------------------------------------------------------+

Loading diagram... Thoracic One-Lung Ventilation Hypoxemia Rescue and Mediastinal Mass Algorithm